COL4A5 and Alport syndrome: Genetic variants of the COL4A3, COL4A4, and COL4A5 genes encoding α3, α4 and α5 type IV collagen polypeptide chains cause structural alterations of the glomerular basement membrane (GBM) that comprise both Alport Syndrome and Thin GBM Disease [1,2].